Seeling W, Kustermann J, Schneider E
Universitätsklinik für Anaesthesiologie, Klinikum der Universität Ulm.
Reg Anaesth. 1990 May;13(3):78-87.
Seventy-five patients scheduled for major abdominal operations were randomly divided into four groups, each with a different postoperative analgesic regime. Group I: buprenorphine 4 micrograms/kg was injected i.v. every 4 h. Groups II-IV: all patients were preoperatively supplied with a thoracic epidural catheter that, however, was not used during the operation. Group II: bupivacaine 0.15 ml/kg was injected epidurally every 2 h, the first dose being 0.5%, the top-ups 0.25%. Group III: buprenorphine 4 micrograms/kg in 10 ml saline was given via the catheter and repeated on request. Group IV: these patients received a combined regime. Bupivacaine was injected as in group II, and in addition buprenorphine was added epidurally in the doses and time intervals of group I. After extubation the patients categorized the intensity of postoperative pain twice, first while lying immobile and then after coughing vigorously, using a rating scale with pain scores from 0 to 10. Thereafter, the analgesic regime described above commenced. One hour later the patients' pain scores were again determined. In addition to pain scores, heart rate (HR), mean arterial pressure (MAP) and paCO2 were recorded at the same points in time. The investigation was then interrupted overnight. The analgesic regime continued as described for groups I and II. Patients in group III received 0.15 mg buprenorphine on request i.v., and in group IV bupivacaine was given as in group II with no further buprenorphine. The study recommenced the next morning at 7:00 a.m. After the initial values (pain scores, HR, MAP, paCO2) had been recorded the analgesic program, as scheduled for each patient, restarted. In group IV buprenorphine was again added to bupivacaine and repeated every 4 h, whereas bupivacaine was injected every 2 h. All values were registered hourly until 7:00 p.m., when the investigation was terminated. RESULTS. On the day of operation and during the first few hours on the morning thereafter, analgesia in groups II and IV was considerably better compared to groups I and III (P less than 0.001). We could not statistically demonstrate, however, that analgesia in group IV was superior to that in group II despite the fact that pain scores were lowest in this group, with a median at rest of 0 throughout the study time. In group III (n = 20), epidural buprenorphine failed to produce any acceptable analgesic effect in 6 patients despite correct catheter position. For this reason they were dropped from the study. No patient in any of the other groups, however, was dropped (P less than 0.01). Later in the 1st postoperative day analgesia in groups II and IV lost its superiority at rest, but coughing continued to be less painful in comparison to groups I and III. We noticed that the duration of action of 0.25% bupivacaine, injected as a bolus, was considerably shorter than expected (less than 2 h) and that several patients experienced pain before the next top-up was given...
75例计划接受腹部大手术的患者被随机分为四组,每组采用不同的术后镇痛方案。第一组:每4小时静脉注射丁丙诺啡4微克/千克。第二至四组:所有患者术前均置入胸段硬膜外导管,但手术期间未使用。第二组:每2小时硬膜外注射布比卡因0.15毫升/千克,首剂为0.5%,追加剂量为0.25%。第三组:通过导管给予10毫升生理盐水中含丁丙诺啡4微克/千克,并根据需要重复给药。第四组:这些患者接受联合方案。布比卡因的注射方式同第二组,此外,还按照第一组的剂量和时间间隔硬膜外追加丁丙诺啡。拔管后,患者使用0至10分的疼痛评分量表对术后疼痛强度进行两次分类,第一次是在静卧不动时,第二次是在剧烈咳嗽后。此后,开始上述镇痛方案。1小时后再次测定患者的疼痛评分。除疼痛评分外,还在相同时间点记录心率(HR)、平均动脉压(MAP)和动脉血二氧化碳分压(PaCO₂)。然后研究中断过夜。镇痛方案继续按照第一组和第二组的描述进行。第三组患者根据需要静脉注射0.15毫克丁丙诺啡,第四组布比卡因的给药方式同第二组,不再追加丁丙诺啡。次日上午7:00研究重新开始。记录初始值(疼痛评分、HR、MAP、PaCO₂)后,按照为每位患者安排的镇痛方案重新开始。第四组在布比卡因基础上再次追加丁丙诺啡,每4小时重复一次,而布比卡因每2小时注射一次。所有数值每小时记录一次,直至晚上7:00研究结束。结果。在手术当天及术后次日清晨的最初几个小时,第二组和第四组的镇痛效果明显优于第一组和第三组(P<0.001)。然而,尽管该组疼痛评分在整个研究期间静息时中位数为0,是最低的,但我们无法从统计学上证明第四组的镇痛效果优于第二组。在第三组(n = 20)中,尽管导管位置正确,但6例患者硬膜外注射丁丙诺啡未产生任何可接受的镇痛效果。因此,他们被排除出研究。然而,其他组没有患者被排除(P<0.01)。在术后第1天晚些时候,第二组和第四组在静息时的镇痛优势消失,但与第一组和第三组相比,咳嗽时的疼痛仍然较轻。我们注意到,单次注射的0.25%布比卡因的作用持续时间明显短于预期(少于2小时),并且有几名患者在下一次追加给药前就出现了疼痛……